ICMR National Institute of Pathology, Safdarjang Campus, Ansari Nagar, New Delhi, 110029, India.
Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurugram Expressway, Faridabad, 121001, India.
Sci Rep. 2022 Mar 28;12(1):5238. doi: 10.1038/s41598-022-09191-z.
Rheumatic heart disease (RHD) is often considered as a disease of developing countries and India is the home of about 40% of RHD patients. Environment seems to play a major role in its causation. Since gene environment interactions can lead to alterations of various metabolic pathways, identification of altered metabolites can help in understanding the various pathways leading to RHD. Blood plasma samples from 51 RHD and 49 healthy controls were collected for the study. Untargeted metabolomics approach was used to identify the metabolites that are altered in RHD patients. Data showed 25 altered metabolites among RHD patients. These altered metabolites were those involved in Purine, Glutamine, Glutamate, Pyrimidine, Arginine, Proline and Linoleic metabolism. Thus, the present study illuminates metabolic alterations among RHD patients which can help in determining the potential therapeutic targets.
风湿性心脏病(RHD)通常被认为是发展中国家的一种疾病,而印度是约 40%的 RHD 患者的所在地。环境似乎在其发病机制中起着主要作用。由于基因-环境相互作用可能导致各种代谢途径的改变,因此鉴定改变的代谢物有助于了解导致 RHD 的各种途径。为了进行这项研究,采集了 51 名 RHD 患者和 49 名健康对照者的血浆样本。本研究采用非靶向代谢组学方法来鉴定 RHD 患者中改变的代谢物。数据显示,RHD 患者中有 25 种改变的代谢物。这些改变的代谢物涉及嘌呤、谷氨酰胺、谷氨酸、嘧啶、精氨酸、脯氨酸和亚油酸代谢。因此,本研究阐明了 RHD 患者中的代谢改变,这有助于确定潜在的治疗靶点。